3 US Senators Propose State Opt-Out for Hemp Product Ban
The hemp product ban is facing new challenges as three US senators propose allowing states to opt out of federal restrictions. This change could create a patchwork of state regulations for intoxicating hemp products. Clinicians must be aware of these…
States Could Opt Out Of Federal Hemp THC Product Ban Under New Bipartisan Senate Bill
The bipartisan senate hemp THC bill proposes allowing states to opt out of the federal hemp THC product ban. This legislation addresses critical regulatory gaps affecting patient access to hemp-derived cannabinoids. It aims to create consistent standards…
First Conviction Against Landlord Enabling Cannabis Factories
The landlord cannabis conviction marks a significant enforcement milestone in the UK. This case targets landlords enabling illegal cannabis cultivation across multiple properties. It highlights challenges in regulated medical cannabis access and illicit…
Prop. 64 at 10: Why the Illicit Cannabis Market Still Dominates in California
California cannabis legalization challenges persist a decade after Prop. 64, with the illicit market still dominating. This affects patient safety due to unregulated product quality and dosing inconsistencies. Clinicians must understand these challenges…
Understanding the Arbitrary Legal Distinction Between Hemp and Marijuana
The arbitrary legal distinction hemp marijuana creates clinical confusion and inconsistent patient access to cannabis medicines. This regulatory framework complicates evidence-based prescribing and challenges clinicians. Understanding this distinction is…
IRS Addresses Cannabis Industry Worker Tips (Newsletter: April 16, 2026)
The 2026 cannabis tax compliance guidance clarifies IRS tip reporting for cannabis industry workers. This regulatory update supports workforce stability and patient access. Clear tax rules help dispensaries maintain consistent service and education.
IIPR and Cannabis Reform: 280E Tax Relief and Schedule III Benefits
The 280E tax relief cannabis businesses could gain significant financial stability, enabling better product consistency and quality control. Schedule III reclassification would open new avenues for clinical research and pharmaceutical development. These…
Virginia Governor Proposes Delaying Launch of Recreational Cannabis Sales
Virginia recreational cannabis delay is creating uncertainty for patients and clinicians. This postponement affects access to regulated products and treatment consistency. Patients currently using cannabis medicinally face challenges due to the delayed…
A letter to the Croton-on-Hudson Planning Board opposing approval of a cannabis dispensary
Local cannabis dispensary zoning impact directly affects patient access to regulated cannabis products. This influences clinical outcomes and patient safety in communities like Croton-on-Hudson. Understanding these zoning decisions is crucial for…
4/20 in Bed-Stuy: Visit Happy Buds Black-Owned Dispensary – Epicenter NYC
Licensed dispensaries in underserved communities like Bed-Stuy improve patient access to safe, regulated cannabis products. This shift supports better clinical outcomes through product consistency and safety. Social equity dispensaries like Happy Buds…